About this tool
This tool scores two bedside screens used in pediatric intensive care. The WAT-1 (Withdrawal Assessment Tool-1) detects iatrogenic withdrawal in children being weaned after days of opioids or benzodiazepines. The CAPD (Cornell Assessment of Pediatric Delirium) screens for delirium, including the quiet hypoactive type that is easily missed.
For the WAT-1, check the last 12 hours of the record (stools, vomiting, temperature), watch the child for 2 minutes, apply a progressive stimulus and time the return to calm; 11 items give 0–12 points. For the CAPD, first confirm the child responds to voice (RASS −3 or above), then rate 8 behaviours over the shift from never to always, compared with what is usual for the child's developmental age; the total is 0–32.
A WAT-1 of 3 or more is consistent with withdrawal: the result tells you to look for other causes, pause or slow the wean, and treat with the same drug class. A CAPD of 9 or more is a positive delirium screen: the result lists causes to look for, non-drug care, cutting benzodiazepines and when antipsychotics may be considered. Sources: Franck et al., Pediatr Crit Care Med 2008; Traube et al., Crit Care Med 2014; SCCM PANDEM guidelines 2022.
Common questions
What WAT-1 score means withdrawal?
A score of 3 or more out of 12 is consistent with iatrogenic withdrawal. Score at least every 12 hours from the first day of weaning until 72 hours after the last opioid or benzodiazepine dose. The WAT-1 cannot tell opioid from benzodiazepine withdrawal.
What CAPD score means delirium?
A total of 9 or more out of 32 is a positive screen. Items 1–4 (eye contact, purposeful actions, awareness, communicating needs) score 4 for never and 0 for always; items 5–8 (restless, inconsolable, underactive, slow to respond) score 0 for never and 4 for always.
Can a sedated child be screened for delirium?
Only if the child responds to voice (RASS −3 or above). At RASS −4 or −5 the child is too deeply sedated to assess; lighten sedation when safe and screen again.
How should withdrawal be treated?
Rule out pain, hypoxia, infection and delirium first. The 2022 SCCM guidelines suggest treating with the same drug class (opioid for opioid withdrawal, benzodiazepine for benzodiazepine withdrawal, alpha-2 agonist for dexmedetomidine or clonidine withdrawal) and using a standardised weaning protocol.